147 related articles for article (PubMed ID: 30249885)
21. miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing.
Belvedere R; Saggese P; Pessolano E; Memoli D; Bizzarro V; Rizzo F; Parente L; Weisz A; Petrella A
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986379
[TBL] [Abstract][Full Text] [Related]
22. Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy.
Chen G; Peng J; Zhu W; Tao G; Song Y; Zhou X; Wang W
Med Oncol; 2014 Nov; 31(11):263. PubMed ID: 25280517
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
25. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
Wang XS; Liu MZ; Zhang CQ; Cai L; Cui NJ
Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915
[TBL] [Abstract][Full Text] [Related]
26. Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.
Bulibu J; Wang W; Tang Y; Li N; Saifuding K
Pathol Oncol Res; 2019 Jan; 25(1):421-427. PubMed ID: 29270777
[TBL] [Abstract][Full Text] [Related]
27. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Huang CC; Shih LH; Chen SW; Li SH
BMC Cancer; 2018 Aug; 18(1):837. PubMed ID: 30126380
[TBL] [Abstract][Full Text] [Related]
28. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
29. Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.
Xu H; Yao Y; Meng F; Qian X; Jiang X; Li X; Gao Z; Gao L
Medicine (Baltimore); 2015 Nov; 94(44):e1558. PubMed ID: 26554762
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
31. Annexin-1-mediated endothelial cell migration and angiogenesis are regulated by vascular endothelial growth factor (VEGF)-induced inhibition of miR-196a expression.
Pin AL; Houle F; Fournier P; Guillonneau M; Paquet ÉR; Simard MJ; Royal I; Huot J
J Biol Chem; 2012 Aug; 287(36):30541-51. PubMed ID: 22773844
[TBL] [Abstract][Full Text] [Related]
32. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
33. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of miR-196a2 expression and Annexin A1 level in children with bronchial asthmaEvaluation of miR-196a2 expression and Annexin A1 level in children.
Ibrahim AA; Ramadan A; Wahby AA; Draz IH; El Baroudy NR; Abdel Hamid TA
Allergol Immunopathol (Madr); 2020; 48(5):458-464. PubMed ID: 32279913
[TBL] [Abstract][Full Text] [Related]
35. TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis.
Liu F; Gong R; He B; Chen F; Hu Z
BMC Cancer; 2018 Sep; 18(1):894. PubMed ID: 30219035
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-196a as a Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma.
Fendereski M; Zia MF; Shafiee M; Safari F; Saneie MH; Tavassoli M
Cancer Invest; 2017 Feb; 35(2):78-84. PubMed ID: 28095062
[TBL] [Abstract][Full Text] [Related]
37. Promising outcomes of definitive chemoradiation and cetuximab for patients with esophageal squamous cell carcinoma.
Chen Y; Wu X; Bu S; He C; Wang W; Liu J; Guo W; Tan B; Wang Y; Wang J
Cancer Sci; 2012 Nov; 103(11):1979-84. PubMed ID: 22845557
[TBL] [Abstract][Full Text] [Related]
38. Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers.
Raulf N; Lucarelli P; Thavaraj S; Brown S; Vicencio JM; Sauter T; Tavassoli M
Eur J Cancer; 2018 Oct; 102():52-68. PubMed ID: 30142511
[TBL] [Abstract][Full Text] [Related]
39. Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma.
Liu S; Lin Z; Zheng Z; Rao W; Lin Y; Chen H; Xie Q; Chen Y; Hu Z
Cancer Sci; 2020 Oct; 111(10):3881-3892. PubMed ID: 32589328
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin treatment modulates Annexin A1 and inhibitor of differentiation to DNA 1 expression in cervical cancer cells.
Prates J; Moreli JB; Gimenes AD; Biselli JM; Pires D'Avila SCG; Sandri S; Farsky SHP; Rodrigues-Lisoni FC; Oliani SM
Biomed Pharmacother; 2020 Sep; 129():110331. PubMed ID: 32768930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
